You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Type 2 Diabetic Nephropathy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of

Active, not recruiting
  • Diabetic Nephropathy
  • Grouping based on previous laboratory results, no intervention.
  • Jinan, Shandong, China
    Qianfoshan Hospital
Oct 24, 2023

Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation

Active, not recruiting
  • Diabetic Nephropathy
  • Grouping based on previous laboratory results, no intervention.
  • Jinan, Shandong, China
    Qianfoshan Hospital
Nov 8, 2023

Diabetic Nephropathies Trial in Daegu (CU01-1001, Placebo)

Recruiting
  • Diabetic Nephropathies
  • Daegu, Korea, Republic of
    Yeongnam University Medical Center
Feb 6, 2023

CKD, Type 2 Diabetes Trial

Not yet recruiting
  • CKD
  • Type 2 Diabetes
    • (no location specified)
    Jan 11, 2023

    CRP to Serum Albumin Ratio in Type 2 DM é Diabetic Nephropathy

    Not yet recruiting
    • Type 2 DM /Diabetic Nephropathy
      • (no location specified)
      Jan 28, 2023

      Technology and Clinical Transformation of Type 2 Diabetes

      Recruiting
      • Diabetic Nephropathy Type 2
      • +2 more
        • Beijing, China
          Chinese PLA General Hospital
        May 25, 2023

        Triglyceride-Glucose Index in Diabetic Nephropathy in Type

        Not yet recruiting
        • Diabetes Mellitus, Type 2
          • (no location specified)
          Oct 28, 2022

          Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy

          Recruiting
          • Diabetic Kidney Disease
            • Beijing, Beijing, China
              Chinese PLA General Hospital
            Mar 16, 2022

            Diabetic Nephropathy Type 2 Trial (Acetylsalicylic Acid, Placebo)

            Not yet recruiting
            • Diabetic Nephropathy Type 2
            • Acetylsalicylic Acid
            • Placebo
            • (no location specified)
            Sep 28, 2023

            Relationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy

            Not yet recruiting
            • Diabetic Nephropathy Type 2
            • Enzyme linked immunosorbent assay
            • (no location specified)
            Jul 4, 2021

            Diabetic Nephropathy Type 2 Trial (Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet)

            Not yet recruiting
            • Diabetic Nephropathy Type 2
            • Tadalafil 20Mg Oral Tablet
            • Pentoxifylline 400 MG Oral Tablet
            • (no location specified)
            Aug 2, 2022

            Through Transcriptomics

            Active, not recruiting
            • Type 2 Diabetes
            • Type 2 Diabetes With Renal Manifestations
              • Mexico City, Mexico
                Hospital Juárez de México
              May 12, 2022

              Diabetic Nephropathy in Qatari Population

              Completed
              • Type 2 Diabetes
                • Doha, Qatar
                  Hamad Medical Corporation
                Apr 29, 2022

                Multidimensional Adversity in Inner-City African American

                Not yet recruiting
                • Diabetic Nephropathy Type 2 - Uncontrolled
                • +2 more
                • Patient and Community Stakeholder Interviews
                • +2 more
                • Milwaukee, Wisconsin
                  Medical College of Wisconsin
                Jan 11, 2023

                Stratification of Type 2 Diabetes Microvascular Complications

                Recruiting
                • Type 2 Diabetes
                • +4 more
                • Diabetes Microvascular Complication Tests
                • Singapore, Singapore
                  Singapore General Hospital
                Mar 14, 2023

                Type 1 Diabetes With Diabetic Nephropathy Trial in Worldwide (Sotagliflozin, Ambrisentan, Ambrisentan and Sotagliflozin)

                Not yet recruiting
                • Type 1 Diabetes Mellitus With Diabetic Nephropathy
                • Aurora, Colorado
                • +6 more
                Oct 2, 2023

                Diabetic Nephropathy in People With Diabetes. Prevalence and

                Recruiting
                • Chronic Kidney Diseases
                • +6 more
                • Kidney Biopsy
                • Skejby, Aarhus, Denmark
                • +9 more
                Mar 15, 2022

                Sleep Apnea, Coronary Atherosclerosis and Heart Failure in

                Completed
                • Sleep Apnea
                • +6 more
                  • Aarhus, Denmark
                    Aarhus University Hospital
                  Feb 4, 2022

                  Type 2 Diabetes With Renal Manifestations Trial in Shanghai (human umbilical cord mesenchymal stem cells, saline)

                  Recruiting
                  • Type 2 Diabetes With Renal Manifestations
                  • human umbilical cord mesenchymal stem cells
                  • saline
                  • Shanghai, Shanghai, China
                    Shanghai East Hospital
                  Dec 16, 2020

                  circANKRD36 as a New Biomarker of Diabetic Nephropathy

                  Not yet recruiting
                  • Diabetic Nephropathy
                  • circANKRD36 as a new biomarker
                  • (no location specified)
                  Sep 28, 2021

                  Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)

                  Not yet recruiting
                  • Diabetic Nephropathy Type 2
                  • Empagliflozin 25 MG
                  • Enalapril Maleate 20 mg
                  • (no location specified)
                  May 9, 2022

                  Diabetic Kidney Disease, Diabetic Nephropathies, Diabetes, Type 2 Trial in Rochester (Autologous adipose-derived mesenchymal

                  Recruiting
                  • Diabetic Kidney Disease
                  • +7 more
                  • Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose
                  • Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose
                  • Rochester, Minnesota
                    Mayo Clinic in Rochester
                  Mar 11, 2022

                  Diabetic Nephropathy Type 2, Biomarker Trial in Hangzhou

                  Recruiting
                  • Diabetic Nephropathy Type 2
                  • Biomarker
                    • Hangzhou, China
                      the Second Affiliated Hospital Zhejiang University Schoolof Medi
                    Jul 14, 2021

                    Diabetic Nephropathy Trial in Chicago, Melbourne, Groningen (Sulodexide, Placebo)

                    Terminated
                    • Diabetic Nephropathy
                    • Chicago, Illinois
                    • +2 more
                    Mar 17, 2021

                    Type 2 Diabetes, Obesity, Bariatric Surgery Candidate Trial in Aurora (Aminohippurate Sodium Inj 20%, Iohexol Inj 300 mg/mL,

                    Recruiting
                    • Type 2 Diabetes Mellitus
                    • +11 more
                    • Aminohippurate Sodium Inj 20%
                    • +3 more
                    • Aurora, Colorado
                      Children's Hospital Colorado
                    Jan 28, 2022